Contact
Please use this form to send email to PR contact of this press release:
ORION BIOTECHNOLOGY SUCCESSFULLY COMPLETES PHASE I CLINICAL STUDY OF 0B-002H TOPICAL GEL FOR HIV PREVENTION
TO:
Please use this form to send email to PR contact of this press release:
ORION BIOTECHNOLOGY SUCCESSFULLY COMPLETES PHASE I CLINICAL STUDY OF 0B-002H TOPICAL GEL FOR HIV PREVENTION
TO: